These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 10544851)

  • 1. Efficacy of folinic acid in reducing methotrexate toxicity in juvenile idiopathic arthritis.
    Ravelli A; Migliavacca D; Viola S; Ruperto N; Pistorio A; Martini A
    Clin Exp Rheumatol; 1999; 17(5):625-7. PubMed ID: 10544851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis.
    Shea B; Swinden MV; Tanjong Ghogomu E; Ortiz Z; Katchamart W; Rader T; Bombardier C; Wells GA; Tugwell P
    Cochrane Database Syst Rev; 2013 May; 2013(5):CD000951. PubMed ID: 23728635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of folic or folinic acid supplementation on the toxicity and efficacy of methotrexate in rheumatoid arthritis: a forty-eight week, multicenter, randomized, double-blind, placebo-controlled study.
    van Ede AE; Laan RF; Rood MJ; Huizinga TW; van de Laar MA; van Denderen CJ; Westgeest TA; Romme TC; de Rooij DJ; Jacobs MJ; de Boo TM; van der Wilt GJ; Severens JL; Hartman M; Krabbe PF; Dijkmans BA; Breedveld FC; van de Putte LB
    Arthritis Rheum; 2001 Jul; 44(7):1515-24. PubMed ID: 11465701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis.
    Ortiz Z; Shea B; Suarez Almazor M; Moher D; Wells G; Tugwell P
    Cochrane Database Syst Rev; 2000; (2):CD000951. PubMed ID: 10796393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis.
    Shea B; Swinden MV; Ghogomu ET; Ortiz Z; Katchamart W; Rader T; Bombardier C; Wells GA; Tugwell P
    J Rheumatol; 2014 Jun; 41(6):1049-60. PubMed ID: 24737913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperhomocysteinemia in children with juvenile idiopathic arthritis is not influenced by methotrexate treatment and folic acid supplementation: a pilot study.
    Huemer M; Födinger M; Huemer C; Sailer-Höck M; Falger J; Rettenbacher A; Bernecker M; Artacker G; Kenzian H; Lang T; Stöckler-Ipsiroglu S
    Clin Exp Rheumatol; 2003; 21(2):249-55. PubMed ID: 12747286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination therapy with methotrexate and cyclosporine A in juvenile idiopathic arthritis.
    Ravelli A; Moretti C; Temporini F; Rossi F; Magni-Manzoni S; Pistorio A; Martini A
    Clin Exp Rheumatol; 2002; 20(4):569-72. PubMed ID: 12175118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The efficacy of folic acid and folinic acid in reducing methotrexate gastrointestinal toxicity in rheumatoid arthritis. A metaanalysis of randomized controlled trials.
    Ortiz Z; Shea B; Suarez-Almazor ME; Moher D; Wells GA; Tugwell P
    J Rheumatol; 1998 Jan; 25(1):36-43. PubMed ID: 9458200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Folinic acid protects against suppression of growth by methotrexate in mice.
    Iqbal MP; Sultana F; Mehboobali N; Pervez S
    Biopharm Drug Dispos; 2001 May; 22(4):169-78. PubMed ID: 11745919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of methotrexate and folinic acid on skeletal growth in mice.
    Iqbal MP; Ahmed M; Umer M; Mehboobali N; Qureshi AA
    Acta Paediatr; 2003 Dec; 92(12):1438-44. PubMed ID: 14971796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leflunomide is associated with a higher flare rate compared to methotrexate in the treatment of chronic uveitis in juvenile idiopathic arthritis.
    Bichler J; Benseler SM; Krumrey-Langkammerer M; Haas JP; Hügle B
    Scand J Rheumatol; 2015; 44(4):280-3. PubMed ID: 25993023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of methotrexate intolerance in juvenile idiopathic arthritis: a prospective, observational cohort study.
    van Dijkhuizen EH; Bulatović Ćalasan M; Pluijm SM; de Rotte MC; Vastert SJ; Kamphuis S; de Jonge R; Wulffraat NM
    Pediatr Rheumatol Online J; 2015; 13():5. PubMed ID: 25745368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Administration of folinic acid after low dose methotrexate in patients with rheumatoid arthritis.
    Buckley LM; Vacek PM; Cooper SM
    J Rheumatol; 1990 Sep; 17(9):1158-61. PubMed ID: 2132565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of medication withdrawal method on flare-free survival in patients with juvenile idiopathic arthritis on combination therapy.
    Chang CY; Meyer RM; Reiff AO
    Arthritis Care Res (Hoboken); 2015 May; 67(5):658-66. PubMed ID: 25220674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Folate usage in MTX-treated juvenile idiopathic arthritis (JIA) patients is inconsistent and highly variable.
    Amarilyo G; Rullo OJ; McCurdy DK; Woo JM; Furst DE
    Rheumatol Int; 2013 Sep; 33(9):2437-40. PubMed ID: 23400770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Folate Supplementation for Methotrexate Therapy in Patients With Rheumatoid Arthritis: A Systematic Review.
    Liu L; Liu S; Wang C; Guan W; Zhang Y; Hu W; Zhang L; He Y; Lu J; Li T; Liu X; Xuan Y; Wang P
    J Clin Rheumatol; 2019 Aug; 25(5):197-202. PubMed ID: 29975207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective effect of folinic acid on low-dose methotrexate genotoxicity.
    Shahin AA; Ismail MM; Saleh AM; Moustafa HA; Aboul-Ella AA; Gabr HM
    Z Rheumatol; 2001 Apr; 60(2):63-8. PubMed ID: 11383050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methotrexate efficacy, but not its intolerance, is associated with the dose and route of administration.
    Fráňová J; Fingerhutová Š; Kobrová K; Srp R; Němcová D; Hoza J; Uher M; Saifridová M; Linková L; Doležalová P
    Pediatr Rheumatol Online J; 2016 Jun; 14(1):36. PubMed ID: 27301536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychological side effects of MTX treatment in juvenile idiopathic arthritis: a pilot study.
    van der Meer A; Wulffraat NM; Prakken BJ; Gijsbers B; Rademaker CM; Sinnema G
    Clin Exp Rheumatol; 2007; 25(3):480-5. PubMed ID: 17631750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methotrexate Hepatotoxicity in Children with Juvenile Idiopathic Arthritis: A Single-Center Study.
    Yassin NA; Haroon M; Elhamshary A
    Curr Rheumatol Rev; 2021; 17(2):242-246. PubMed ID: 33308133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.